Moody Aldrich Partners’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CIP
WHG
Moody Aldrich Partners's CNMD Position: Q1 2024 in Review
Moody Aldrich Partners sold out of CONMED (CNMD) in Q1 2024, closing a stake of 39,100 shares — an estimated $4.28M sold.
Moody Aldrich Partners first reported a position in CNMD in Q2 2018 and held it in 22 quarters. The position peaked at $10.3M in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.
- Moody Aldrich Partners reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
- Moody Aldrich Partners sold 39,100 CONMED shares in Q1 2024, an estimated $4.28M.
- Moody Aldrich Partners first reported a position in CONMED in Q2 2018 and held it in 22 quarters.
- Moody Aldrich Partners's CONMED position peaked at $10.3M in Q1 2022.
- 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.
Based on Moody Aldrich Partners's 13F filing for Q1 2024, filed 30 Apr 2024.